{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:43:34Z","timestamp":1774007014715,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11894-015-0434-4","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T10:18:18Z","timestamp":1425464298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of Hepatic Adenomatosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Manish","family":"Thapar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Grapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"issue":"5","key":"434_CR1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/0016-5085(85)90220-3","volume":"89","author":"JF Flejou","year":"1985","unstructured":"Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology. 1985;89(5):1132\u20138.","journal-title":"Gastroenterology"},{"issue":"3","key":"434_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","volume":"43","author":"J Zucman-Rossi","year":"2006","unstructured":"Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43(3):515\u201324.","journal-title":"Hepatology"},{"issue":"3","key":"434_CR3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46(3):740\u20138.","journal-title":"Hepatology"},{"key":"434_CR4","doi-asserted-by":"crossref","unstructured":"Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenomatosis: what should the term stand for. Clin Res Hepatol Gastroenterol. 2014;38(2).","DOI":"10.1016\/j.clinre.2013.08.004"},{"issue":"7","key":"434_CR5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","volume":"242","author":"JB Rooks","year":"1979","unstructured":"Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA. 1979;242(7):644\u20138.","journal-title":"JAMA"},{"issue":"5","key":"434_CR6","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.gastro.2013.02.032","volume":"144","author":"JC Nault","year":"2013","unstructured":"Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors\u2014from molecular classification to personalized clinical care. Gastroenterology. 2013;144(5):888\u2013902. Review article summarizing current understanding of pathological classification of hepatic adenomas using novel immunohistochemical techniques. It also discusses the molecular pathways in adenoma development.","journal-title":"Gastroenterology"},{"key":"434_CR7","author":"S Agrawal","year":"2014","unstructured":"Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol. 2014. doi: 10.1016\/j.cgh.2014.05.02 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"434_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820510028954","volume":"7","author":"L Barthelmes","year":"2005","unstructured":"Barthelmes L, Tait IS. Liver cell adenoma and liver cell adenomatosis. HPB (Oxford). 2005;7(3):186\u201396.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"434_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1272837","volume":"31","author":"P Bioulac-Sage","year":"2011","unstructured":"Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis. 2011;31(1):91\u2013103. Description of immunohistochemistry techniques used to identify different subtypes of hepatocellular adenomas. It also discusses the performance characteristics of these techniques.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"434_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-86-2-180","volume":"86","author":"HA Edmondson","year":"1977","unstructured":"Edmondson HA, Reynold TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Int Med. 1977;86(2):180\u20132.","journal-title":"Ann Int Med"},{"issue":"5","key":"434_CR11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2214\/AJR.07.3419","volume":"191","author":"A Furlan","year":"2008","unstructured":"Furlan A, van der Windt DJ, Nalesnik MA, Sholosh B, Ngan KK, Pealer KM, et al. Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case\u2013control study. AJR Am J Roentgenol. 2008;191(5):1430\u20135.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"434_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00261-013-0056-y","volume":"39","author":"S Srirattanapong","year":"2014","unstructured":"Srirattanapong S, Angthong W, Kim BS, Hayashi PH, Gerber DA, Woosley JT, et al. Liver adenomatosis: serial investigation on MRI. Abdom Imaging. 2014;39(2):269\u201382. This is a retrospective series of 18 patients with liver adenomatosis and summarizes MRI findings and clinical course.","journal-title":"Abdom Imaging"},{"issue":"6","key":"434_CR13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2036.2011.04772.x","volume":"34","author":"C Bunchorntavakul","year":"2011","unstructured":"Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, et al. Clinical history and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011;34(6):664\u201374. The authors evaluate the role of obesity and metabolic syndrome in the development of hepatic adenomas. These disorders play an important role in the inflammatory subtype of hepatic adenomas.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"434_CR14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","volume":"32","author":"P Bioulac-Sage","year":"2013","unstructured":"Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma sub-types: the impact of overweight and obesity. Liver Int. 2013;32(8):1217\u201321. The authors evaluate the role of obesity in hepatic adenoma development.","journal-title":"Liver Int"},{"issue":"3","key":"434_CR15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0016-5085(81)90606-5","volume":"81","author":"P Parker","year":"1981","unstructured":"Parker P, Burr I, Slonim A, Ghishan FK, Greene H. Regression of hepatic adenomas in type 1a glycogen storage disease with dietary therapy. Gastroenterology. 1981;81(3):534\u20136.","journal-title":"Gastroenterology"},{"issue":"19","key":"434_CR16","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1074\/jbc.M610725200","volume":"282","author":"S Rebouissou","year":"2007","unstructured":"Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, et al. HNF-1a inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007;282(19):14437\u201346.","journal-title":"J Biol Chem"},{"issue":"5","key":"434_CR17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.gastro.2003.07.012","volume":"125","author":"Y Bacq","year":"2003","unstructured":"Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 2003;125(5):1470\u20135.","journal-title":"Gastroenterology"},{"key":"434_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","volume":"457","author":"S Rebouissou","year":"2009","unstructured":"Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;457:200\u20134.","journal-title":"Nature"},{"issue":"5","key":"434_CR19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2004.02.005","volume":"126","author":"V Paradis","year":"2004","unstructured":"Paradis V, Benzerkri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V, et al. Telengiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004;126(5):1323\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"434_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/gut.2006.0106245","volume":"56","author":"A Sa Cunha","year":"2007","unstructured":"Sa Cunha A, Blanc JF, Lazaro E, Mellottee L, Le Bail B, Zucman-Rossi J, et al. Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut. 2007;56(2):307\u20139.","journal-title":"Gut"},{"key":"434_CR21","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1245\/s10434-008-0090-0","volume":"15","author":"SW Cho","year":"2008","unstructured":"Cho SW, Marsh J, Steel J. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795\u2013803.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"434_CR22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2009.07.061","volume":"137","author":"S Dokmak","year":"2009","unstructured":"Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137(5):1698\u2013705.","journal-title":"Gastroenterology"},{"key":"434_CR23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1245\/s10434-008-0275-6","volume":"16","author":"JL Deneve","year":"2009","unstructured":"Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16:640\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"434_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.22995","volume":"50","author":"P Bioulac-Sage","year":"2009","unstructured":"Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481\u20139.","journal-title":"Hepatology"},{"issue":"7","key":"434_CR25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/archsurg.1994.01420310044007","volume":"129","author":"JH Foster","year":"1994","unstructured":"Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg. 1994;129(7):712\u20137.","journal-title":"Arch Surg"},{"issue":"1","key":"434_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","volume":"60","author":"O Farges","year":"2010","unstructured":"Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2010;60(1):85\u20139.","journal-title":"Gut"},{"issue":"4","key":"434_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-105-4-547","volume":"105","author":"SC Gordon","year":"1986","unstructured":"Gordon SC, Reddy KR, Livingstone AS, Jeffers LJ, Schiff ER. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Int Med. 1986;105(4):547\u20139.","journal-title":"Ann Int Med"},{"issue":"6","key":"434_CR28","first-page":"296","volume":"105","author":"H Tesluk","year":"1981","unstructured":"Tesluk H, Lawrie J. Hepatocellular adenoma: its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med. 1981;105(6):296\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"434_CR29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.rcl.2005.05.006","volume":"43","author":"SM Hussain","year":"2005","unstructured":"Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin N Am. 2005;43(5):929\u201347. doi: 10.1016\/j.rcl.2005.05.006 . ix.","journal-title":"Radiol Clin N Am"},{"issue":"2","key":"434_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mric.2005.03.007","volume":"13","author":"SM Hussain","year":"2005","unstructured":"Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am. 2005;13(2):255\u201375. doi: 10.1016\/j.mric.2005.03.007 .","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"9","key":"434_CR31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archsurg.136.9.1033","volume":"136","author":"T Terkivatan","year":"2001","unstructured":"Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg. 2001;136(9):1033\u20138.","journal-title":"Arch Surg"},{"issue":"3","key":"434_CR32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1148\/radiology.214.3.r00mr28861","volume":"214","author":"T Ichikawa","year":"2000","unstructured":"Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology. 2000;214(3):861\u20138. doi: 10.1148\/radiology.214.3.r00mr28861 .","journal-title":"Radiology"},{"issue":"3","key":"434_CR33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00261-012-9906-2","volume":"38","author":"SP Raman","year":"2013","unstructured":"Raman SP, Hruban RH, Fishman EK. Hepatic adenomatosis: spectrum of imaging findings. Abdom Imaging. 2013;38(3):474\u201381. The authors discuss the imaging characteristics and differential diagnosis of hepatic adenomas.","journal-title":"Abdom Imaging"},{"issue":"4","key":"434_CR34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1148\/radiographics.21.4.g01jl04877","volume":"21","author":"L Grazioli","year":"2001","unstructured":"Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics. 2001;21(4):877\u201392.","journal-title":"Radiographics"},{"issue":"5","key":"434_CR35","doi-asserted-by":"crossref","first-page":"W290","DOI":"10.2214\/AJR.07.3198","volume":"190","author":"O Giovanoli","year":"2008","unstructured":"Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann HP. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol. 2008;190(5):W290\u20133.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"434_CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/RCT.0b013e31820bad61","volume":"35","author":"A Shanbhogue","year":"2011","unstructured":"Shanbhogue A, Shan SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011;35(2):159\u201366.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"434_CR37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.22417","volume":"48","author":"H Laumonier","year":"2008","unstructured":"Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808\u201318.","journal-title":"Hepatology"},{"issue":"4","key":"434_CR38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1478-3231.2008.01669.x","volume":"28","author":"R Vetelainen","year":"2008","unstructured":"Vetelainen R, Erdogan D, de Graaf W, ten Kate F, Jansen PL, Gouma DJ, et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int. 2008;28(4):499\u2013508.","journal-title":"Liver Int"},{"issue":"12","key":"434_CR39","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.5858\/132.12.1951","volume":"132","author":"WO Greaves","year":"2008","unstructured":"Greaves WO, Bhattacharya B. Hepatic adenomatosis. Arch Pathol Lab Med. 2008;132(12):1951\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"434_CR40","doi-asserted-by":"crossref","unstructured":"Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. 2014. The authors review the molecular and genetic biology of hepatic adenomas along with immunohistochemical and histopathological charaterstics.","DOI":"10.5858\/arpa.2013-0183-RA"},{"issue":"31","key":"434_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2011.02667.x","volume":"32","author":"WC Aalten SM Van","year":"2012","unstructured":"Van Aalten SM WC, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32(31):28\u201337. Summarized current diagnostic and current treatment options for hepatic adenomas. The authors propose a decision model for adenoma management.","journal-title":"Liver Int"},{"key":"434_CR42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/MCG.0b013e3181f97747","volume":"45","author":"CH Wilson","year":"2011","unstructured":"Wilson CH, Manas DM, French JJ. Laparoscopic liver resection for hepatic adenoma in pregnancy. J Clin Gastroenterol. 2011;45:828\u201333.","journal-title":"J Clin Gastroenterol"},{"key":"434_CR43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/000313489906501115","volume":"65","author":"H Yoshidome","year":"1999","unstructured":"Yoshidome H, Morita K, Edwards M. Management issues regarding hepatic adenomatosis. Am Surg. 1999;65:1070\u20136.","journal-title":"Am Surg"},{"issue":"5","key":"434_CR44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/lt.500040505","volume":"4","author":"A Ribeiro","year":"1998","unstructured":"Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transplant Surg. 1998;4(5):388\u201398.","journal-title":"Liver Transplant Surg"},{"key":"434_CR45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-2007-1007310","volume":"14","author":"RL Jenkins","year":"1994","unstructured":"Jenkins RL, Johnson L, Lewis D. Surgical approach to benign liver tumors. Semin Liver Dis. 1994;14:178\u201389.","journal-title":"Semin Liver Dis"},{"issue":"9","key":"434_CR46","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/ajg.2014.213","volume":"109","author":"JA Marrero","year":"2014","unstructured":"Marrero JA, Ahn J, Reddy R. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328\u201347.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"434_CR47","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cgh.2013.09.017","volume":"12","author":"SK Venkatesh","year":"2014","unstructured":"Venkatesh SK, Vishal C, Lewis RR. Liver masses: a clinical, radiological, and pathologic perspective. Clin Gastroenterol Hepatol. 2014;12(9):1414\u201329.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"434_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000268427","volume":"27","author":"VA Huurman","year":"2010","unstructured":"Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Dig Surg. 2010;27:56\u201360.","journal-title":"Dig Surg"},{"key":"434_CR49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12072-009-9126-1","volume":"3","author":"S Kobayashi","year":"2009","unstructured":"Kobayashi S, Sakaguchi H, Takatsuka M, Suekane M, Iwai S, Morikawa H, et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int. 2009;3:416\u201320.","journal-title":"Hepatol Int"},{"issue":"8 Pt 2","key":"434_CR50","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1111\/j.1440-1746.2007.05177.x","volume":"23","author":"H Rhim","year":"2008","unstructured":"Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol. 2008;23(8 Pt 2):e422\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"434_CR51","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1440-1746.2006.03184.x","volume":"21","author":"S Fujita","year":"2006","unstructured":"Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson D, et al. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol. 2006;21(8):1351\u20134.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"434_CR52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000323746","volume":"28","author":"SM Aalten Van","year":"2011","unstructured":"Van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Dig Surg. 2011;28(3):173\u20137.","journal-title":"Dig Surg"},{"issue":"Suppl 1","key":"434_CR53","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1111\/tri.1992.5.s1.201","volume":"5","author":"IR Marino","year":"1992","unstructured":"Marino IR, Scantlebury VP, Bronsther O, Iwatsuki S, Starzl TE. Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int. 1992;5 Suppl 1:S201\u20135.","journal-title":"Transpl Int"},{"issue":"7","key":"434_CR54","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0003-3944(01)00577-6","volume":"126","author":"PJ Yunta","year":"2001","unstructured":"Yunta PJ, Moya A, San-Juan F, Lopez-Andujar R, De Juan M, Orbis F, et al. A new case of hepatic adenomatosis treated with orthotopic liver transplantation. Ann Chir. 2001;126(7):672\u20134.","journal-title":"Ann Chir"},{"issue":"3","key":"434_CR55","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1111\/j.1399-3046.2008.01123.x","volume":"14","author":"JR Wellen","year":"2010","unstructured":"Wellen JR, Anderson CD, Doyle M, Shenoy S, Nadler M, Turmelle Y, et al. The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature. Pediatr Transplant. 2010;14(3):E16\u20139.","journal-title":"Pediatr Transplant"},{"issue":"12","key":"434_CR56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1432-2277.2003.tb00258.x","volume":"16","author":"JP Lerut","year":"2003","unstructured":"Lerut JP, Ciccarelli O, Sempoux C, Danse E, DeFlandre J, Horsmans Y, et al. Glycogenosis storage type I diseases and evolution adenomatosis: an indication for liver transplantation. Transpl Int. 2003;16(12):879\u201384.","journal-title":"Transpl Int"},{"issue":"1","key":"434_CR57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2010.10.030","volume":"55","author":"SM Aalten Van","year":"2011","unstructured":"Van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, De Man RA, Ijzermans JN. J Hepatol. 2011;55(1):120\u20135.","journal-title":"J Hepatol"},{"issue":"2","key":"434_CR58","first-page":"148","volume":"51","author":"DR Kent","year":"1978","unstructured":"Kent DR, Nissen ED, Nissen SE, Ziehm DJ. Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol. 1978;51(2):148\u201351.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"434_CR59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cgh.2011.03.007","volume":"9","author":"O Shaked","year":"2011","unstructured":"Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol. 2011;9(7):547\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"434_CR60","doi-asserted-by":"crossref","unstructured":"Broker ME, Ijzermans JN, Van Aalten SM, De Man RA, Terkivatan T. The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach. Int J Hepatol. 2012:1\u20133. The article summarizes the management of hepatic adenomas in pregnant patients and proposes an algorithm for management.","DOI":"10.1155\/2012\/725735"},{"issue":"3","key":"434_CR61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2010.07.022","volume":"54","author":"JE Noels","year":"2011","unstructured":"Noels JE, Van Aalten SM, Van der Windt DJ, Kok NF, De Man RA, Terkivatan T, et al. Management of hepatocellular adenoma during pregnancy. J Hepatol. 2011;54(3):553\u20138. This article describes the outcomes of 17 pregnancies in 12 patients previously diagnosed with hepatic adenomas. The authors make suggestions for management based on their experience.","journal-title":"J Hepatol"},{"issue":"1","key":"434_CR62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13304-013-0222-3","volume":"66","author":"A Cristiano","year":"2013","unstructured":"Cristiano A, Dietrich A, Spina JC, Ariles V, De Santibanes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updat Surg. 2013;66(1):9\u201321.","journal-title":"Updat Surg"},{"issue":"12","key":"434_CR63","doi-asserted-by":"crossref","first-page":"e27090","DOI":"10.4161\/onci.27090","volume":"2","author":"K Poussin","year":"2013","unstructured":"Poussin K, Pilati C, Couchy G, Calderado J, Bioulac-Sage P, Bacq Y, et al. Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma. Oncoimmunology. 2013;2(12):e27090.","journal-title":"Oncoimmunology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-015-0434-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-015-0434-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-015-0434-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T16:17:16Z","timestamp":1717777036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-015-0434-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s11894-015-0434-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]},"article-number":"12"}}